Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) was the recipient of a large increase in short interest in August. As of August 15th, there was short interest totalling 500 shares, an increase of 66.7% from the July 31st total of 300 shares. Based on an average daily volume of 400 shares, the days-to-cover ratio […]
Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six brokerages that are presently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The […]
Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report)’s stock price reached a new 52-week high on Wednesday . The company traded as high as GBX 1,960 ($25.63) and last traded at GBX 1,944 ($25.42), with a volume of 157976 shares. The stock had previously closed at GBX 1,879.50 ($24.58). Analyst Upgrades and Downgrades Several brokerages […]
Hikma Pharmaceuticals (LON:HIK – Free Report) had its price target boosted by Barclays from GBX 1,700 ($21.87) to GBX 1,800 ($23.16) in a research report sent to investors on Wednesday, MarketBeat Ratings reports. The brokerage currently has an equal weight rating on the stock. Separately, Jefferies Financial Group raised their target price on Hikma Pharmaceuticals […]
Hikma Pharmaceuticals PLC (OTCMKTS:HKMPF – Get Rating)’s stock price reached a new 52-week high during mid-day trading on Monday . The company traded as high as $23.17 and last traded at $23.17, with a volume of 0 shares traded. The stock had previously closed at $23.17. Wall Street Analyst Weigh In HKMPF has been the […]